The Global Veterinary Antiseptic Market was valued at approximately USD 3.47 billion in 2023 and is anticipated to grow to at a compound annual growth rate (CAGR) of 7.2% during the forecast period ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

Strategies that practices can implement to prevent veterinary burnout were discussed during a session at the 2024 Fetch ...

Equine Veterinary Therapeutics MarketThe global equine veterinary therapeutics market is poised for significant expansion, ...

Veterinary Glucometers MarketThe veterinary glucometers market is set for robust growth, with a projected value of USD 351.3 ...

Veterinary technicians are crucial to pet healthcare and the demand and necessity for this key role has continued to increase post pet boom. However, 47% of pet owners are unaware of how impactful a ...

The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% over the past three months. However, stock prices are usually driven by a company ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

Not One More Vet is a nonprofit organization whose mission is to transform the status of mental wellness within the profession so veterinary professionals can survive and thrive through education, ...

Merck's Keytruda could face competition from a newer medicine. The company's crown jewel will also lose patent exclusivity in a few years. Merck should have the means to get around these headwinds ...